USTDA-funded engagement will strengthen AI governance and readiness while supporting clinical pilots at Jordan’s leading cancer treatment centre.
ReMedi Health Solutions, a healthcare IT consulting firm, has been selected as the US prime contractor to lead an AI readiness initiative at Jordan’s King Hussein Cancer Center (KHCC).
The engagement is funded through a Technical Assistance grant from the US Trade and Development Agency (USTDA) to the King Hussein Cancer Foundation (KHCF) and supports KHCC’s Office of Artificial Intelligence and Information Innovations.
The USTDA-funded technical assistance will support KHCC in strengthening its AI governance, readiness and implementation planning while advancing three pilots focused on business intelligence, breast cancer diagnostics and clinical trials screening.
The project will also identify US firms and technology providers that may support KHCC with additional AI technologies after the engagement. Together, these efforts help KHCC evaluate practical AI applications for earlier detection, better-informed care decisions, operational visibility and sustainable adoption in clinical and administrative workflows.
“Expanding the use of AI will help reduce administrative burdens, support clinical decision-making, provide personalized medicine and an improved experience and enhance KHCC’s research capabilities,” said Dr. Asem Mansour, CEO, KHCC.
KHCC treats approximately 60% of cancer cases diagnosed in Jordan and is a regional hub for advanced cancer treatments for patients in the Middle East, making it one of the most concentrated cancer care environments in the region.
The centre operates within Jordan’s national Hakeem electronic health record (EHR) ecosystem, a mature, VistA-based environment that carries active patient care. Most AI guidance assumes a cloud-native data layer that real hospitals rarely have. ReMedi designs its approach around the EHR clinicians actually use, building AI into specialty workflows to support clinician experience and adoption.
“AI succeeds in a hospital when it respects how clinicians and operations work together,” said Sonny Hyare, MD, CEO, ReMedi Health Solutions. “KHCC has a clear mandate and a complex environment, which is exactly where clinically led execution matters most. Our job is to help the center move from AI interest to AI readiness in a way that holds up at the point of care.”
The engagement reflects collaboration across institutions. In partnership with ReMedi, the King Hussein Cancer Foundation and KHCC provide clinical and institutional leadership and USTDA provides funding aligned with the US Partnership for Global Infrastructure and Investment and Jordan’s Artificial Intelligence Strategy and Implementation Plan 2023-2027.
Electronic Health Solutions, the national digital health organisation behind Hakeem, provides the EHR interface and integration the pilots run on. ReMedi’s technology partner, Folio3, brings AI-first engineering and healthcare-specific expertise across EHR integration and clinical data engineering to power KHCC’s three pilots. By embedding AI at the core of clinical workflows, Folio3 transforms these pilots into practical, intelligent tools that care teams can rely on every day.
